Prot# 056-00: A Phase II/III Randomized, Double-Blind Study of Paclitaxel plus Carboplatin in Combination with Vorinostat or Placebo in Patients with Stage IIIB (with pleural effusion) or Stage IV Non-Small-Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/19/077/19/10

Funding

  • Merck & Co., Inc. (056-00)